This application note highlights the separation of clozapine on Oasis MCX.
Clozapine is used to treat schizophrenia in patients who have not been helped by or are unable to take other medicines. The analyte is basic and therefore an Oasis MCX product was selected.
Oasis MCX 10-mg 96-Well Plate |
|
Condition: |
500 μL MeOH |
Equilibrate: |
500 μL H2O |
Load: |
1 mL sample (500 μL human plasma diluted 1:1 with 4% H3PO4 in H2O) |
Wash 1: |
500 μL 2% HCOOH in H2O |
Wash 2: |
500 μL MeOH |
Elute: |
300 μL (150 μL x 2) 5% NH4OH in MeOH Dry and reconstitute w/100 μL 0.1% FA in H2O |
Inject: |
50 μL |
Column: |
SunFire C18 2.1 x 50 mm, 3.5 μm |
Mobile Phase A: |
0.1% FA in H2O |
Mobile Phase B: |
0.1% FA in MeOH |
Flow Rate: |
0.4 mL /min |
Injection Volume: |
50 μL |
Instrument: |
2777 Sample Manager and 1525μ Binary HPLC Pump |
Quattro Premier |
|
---|---|
ESI+ |
|
Source Temp.: |
150 °C |
Desolvation Temp.: |
350 °C |
Cone Gas Flow: |
50 L /Hr |
Desolvation Gas Flow: |
600 L /Hr |
Collision Cell: |
2.2e-3 bar (Ar gas) |
WA60086, June 2007